Michael D. Lewis, Ph.D.
Dr. Lewis received his B.S. degree from the Massachusetts Institute of Technology and his Ph.D. from Harvard University.
Michael Lewis has over thirty years’ experience in the pharmaceutical industry discovering and developing small molecule and biological products before joining the Edward P. Evans Foundation in 2014. For many years he led the pharmaceutical discovery research at a major discovery laboratory subsidiary of Eisai Co., Ltd., focusing on new technologies for the treatment of cancer and immunological disorders. Dr. Lewis believes that recent scientific advancements in hematology hold great promise for the discovery and development of transformational MDS therapies that could make a real difference in the lives of patients. He believes that the Edward P. Evans Foundations is ideally positioned to catalyze these advances.